Data analysis on hepatitis B through pilot surveillance reporting system in Henan province, 2012-2016.
10.3760/cma.j.issn.0254-6450.2018.04.023
- Author:
Y H GUO
1
;
Y Y LYU
;
J H YANG
;
J XU
;
J LI
;
Y YE
;
Y Y ZHANG
Author Information
1. Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China.
- Publication Type:Journal Article
- Keywords:
Epidemiology;
Hepatitis B;
Surveillance
- MeSH:
China/epidemiology*;
Cities;
Disease Notification/statistics & numerical data*;
Hepatitis A/epidemiology*;
Hepatitis B/epidemiology*;
Hepatitis B Antibodies/blood*;
Hepatitis B Surface Antigens/blood*;
Humans;
Incidence;
Pilot Projects;
Population Surveillance;
Sentinel Surveillance
- From:
Chinese Journal of Epidemiology
2018;39(4):500-504
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To standardize the reporting system on hepatitis B in order to improve the quality of monitoring program in Henan province. Methods: A total of 6 sites of Hepatitis B pilot surveillance were selected in Xinzheng of Zhengzhou city, Linzhou of Anyang city, Shanyang district of Jiaozuo city, Shaoling district of Luohe city, Yongcheng of Shangqiu city, Pingqiao district of Xinyang city in Henan province. Subjects under study were those reported hepatitis B cases, from 2012 to 2016. Cases diagnosed in 2011 were chosen as controls. Data on classification of hepatitis B, time that HBsAg became positive and ALT value of the cases were analyzed annually. 5 ml venous blood was collected and anti-HBc IgM confirmed test was made for those suspected acute cases on hepatitis B. Based on the 2016 data from the monitoring system, the incidence of acute hepatitis B in Henan province was estimated. Results: The number of reported hepatitis B cases had declined in 6 sites of Hepatitis B pilot surveillance substantially. A total of 17 436 hepatitis B reported in 2011 but only 2 632 cases were reported in 2016, with a reduction of 84.90%(14 804/17 436) in these six monitoring sites. The number of unclassified hepatitis B cases also dropped sharply. In 2011, 36.87% of the cases were unclassified, but the figure reduced to 0.08% in 2016, from the six sites. The rate on ALT detection also gradually improved. The rate of misdiagnosis on HBV carrier from hepatitis B almost disappeared. From 2013 to 2016, 777 blood samples were collected from six pilot sites. 29.34% (228/777) of the blood samples were tested positive for anti-HBc IgM after confirmed by the hepatitis laboratory of the China Center for Disease Control and Prevention. Conclusions: Since the development of the pilot surveillance program, the quality of reporting system on hepatitis B had been improved, as well as the accuracy of diagnosis. Rate on the accuracy of reporting on hepatitis B and the methods of testing should be improved at the monitoring sites.
